Case Report
Daratumumab as first line therapy in primary effusion lymphoma: a case report
Annals of Lymphoma
2021;
5:
33
.
(30 December 2021)
Review Article
Minimal residual disease in follicular lymphoma
Annals of Lymphoma
2021;
5:
32
.
(30 December 2021)
Review Article
From pathobiology to targeted treatment in Epstein Barr virus related T cell and Natural Killer cell lymphoproliferative diseases
Annals of Lymphoma
2021;
5:
31
.
(30 December 2021)
Review Article
The contribution of ebv to the pathogenesis of classical hodgkin lymphoma
Annals of Lymphoma
2021;
5:
30
.
(30 September 2021)
Review Article
Adult T-cell leukemia/lymphoma—pathobiology and implications for modern clinical management
Annals of Lymphoma
2021;
5:
29
.
(30 September 2021)
Review Article
Tumor microenvironment of follicular lymphoma
Annals of Lymphoma
2021;
5:
28
.
(30 September 2021)
Review Article
Primary central nervous system lymphoma: advances in MRI and PET imaging
Annals of Lymphoma
2021;
5:
27
.
(30 September 2021)
Review Article
HIV-associated lymphoma—advances in clinical management
Annals of Lymphoma
2021;
5:
26
.
(30 September 2021)
Review Article
Primary central nervous system lymphoma in older adults and the rationale for maintenance strategies: a narrative review
Annals of Lymphoma
2021;
5:
25
.
(30 September 2021)
Review Article
Epstein-Barr virus-associated lymphoproliferative disorders in immunosuppressed patients
Annals of Lymphoma
2021;
5:
24
.
(30 September 2021)
Review Article
Relapsed and refractory primary CNS lymphoma: treatment approaches in routine practice
Annals of Lymphoma
2021;
5:
23
.
(30 September 2021)
Review Article
Reframing Burkitt lymphoma: virology not epidemiology defines clinical variants
Annals of Lymphoma
2021;
5:
22
.
(30 September 2021)
Editorial
Preface: why this special series on marginal zone lymphomas?
Annals of Lymphoma
2021;
5:
21
.
(30 September 2021)
Review Article
Overcoming the blood-brain barrier in primary central nervous system lymphoma: a review on new strategies to solve an old problem
Annals of Lymphoma
2021;
5:
20
.
(30 June 2021)
Review Article
Narrative review: biomarkers, a hope towards early diagnosis in primary CNS lymphoma
Annals of Lymphoma
2021;
5:
19
.
(30 June 2021)
Review Article
Genetic heterogeneity in follicular lymphoma
Annals of Lymphoma
2021;
5:
18
.
(30 June 2021)
Review Article
Overview of the current treatment strategy in extranodal NK/T-cell lymphoma: from diagnosis to recurrence
Annals of Lymphoma
2021;
5:
17
.
(30 June 2021)
Review Article
Primary central nervous system lymphoma: epidemiology and clinical presentation
Annals of Lymphoma
2021;
5:
16
.
(30 June 2021)
Review Article
Positron emission tomography and magnetic resonance imaging in primary central nervous system lymphoma—a narrative review
Annals of Lymphoma
2021;
5:
15
.
(30 June 2021)
Review Article
Management of relapsed follicular lymphoma
Annals of Lymphoma
2021;
5:
14
.
(30 June 2021)
Review Article
Narrative review of primary central nervous system lymphoma: treatment-related neurotoxicity
Annals of Lymphoma
2021;
5:
13
.
(30 June 2021)
Review Article
Molecular insights into the pathogenesis of follicular lymphoma
Annals of Lymphoma
2021;
5:
12
.
(30 June 2021)
Review Article
Predicting early progression in follicular lymphoma
Annals of Lymphoma
2021;
5:
11
.
(30 June 2021)
Review Article
Frontline management for follicular lymphoma patients: a narrative review
Annals of Lymphoma
2021;
5:
10
.
(30 March 2021)
Review Article
Novel immunotherapy in follicular lymphoma: a narrative review
Annals of Lymphoma
2021;
5:
9
.
(30 March 2021)